Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
439 studies found for:    Waldenstrom
Show Display Options
Rank Status Study
1 Completed
Has Results
Perifosine in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia
Condition: Waldenstrom's Macroglobulinemia
Intervention: Drug: Perifosine
2 Completed Sildenafil Citrate in Waldenstrom's Macroglobulinemia
Condition: Waldenstrom's Macroglobulinemia
Intervention: Drug: Sildenafil citrate (Viagra)
3 Completed Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia
Condition: Waldenstrom Macroglobulinemia
Intervention: Drug: Thalidomide
4 Active, not recruiting LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's Macroglobulinemia
Condition: Waldenstrom's Macroglobulinemia
Intervention: Drug: LBH589
5 Completed Efficacy of Bortezomib (Velcade(R)) in Patients With Advanced Waldenström Macroglobulinemia
Condition: Waldenstrom Macroglobulinemia
Intervention: Drug: BORTEZOMIB
6 Completed Bortezomib (Velcade) in Waldenstrom's Macroglobulinemia
Conditions: Waldenstrom's Macroglobulinemia;   Lymphoplasmacytic Lymphoma
Intervention: Drug: Bortezomib (Velcade)
7 Suspended Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia
Condition: Waldenstrom's Macroglobulinemia
Intervention: Drug: GS-1101
8 Recruiting Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's Macroglobulinemia
Condition: Waldenstrom's Macroglobulinemia
Interventions: Drug: Ixazomib;   Drug: Dexamethasone;   Drug: Rituximab
9 Recruiting Study of Ibrutinib in Patients With Symptomatic, Previously Untreated Waldenstrom's Macroglobulinemia, and Impact on Tumor Genomic Evolution Using Whole Genome Sequencing
Condition: Waldenstrom's Macroglobulinemia
Intervention: Drug: Ibrutinib
10 Active, not recruiting Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia
Condition: Waldenstrom's Macroglobulinemia
Intervention: Drug: IMO-8400
11 Completed
Has Results
A Phase II Trial of Ofatumumab in Subjects With Waldenstrom's Macroglobulinemia
Condition: Waldenstrom Macroglobulinaemia
Intervention: Biological: Ofatumumab
12 Active, not recruiting Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia
Condition: Waldenstrom's Macroglobulinemia
Interventions: Drug: Everolimus;   Drug: Rituximab;   Drug: Bortezomib
13 Recruiting Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia
Condition: Waldenstrom Macroglobulinemia
Intervention: Drug: ABT199
14 Recruiting Expression of Ku70/XRCC6 in Waldenström's Macroglobulinemia
Condition: Waldenström Macroglobulinemia
Intervention: Biological: Blood or bone marrow samples
15 Terminated
Has Results
CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia
Condition: Waldenstrom's Macroglobulinemia
Interventions: Drug: CC-5103 (lenalidomide);   Drug: Rituximab
16 Active, not recruiting Study of Lenalidomide in Relapse/Refractory Waldenstrom Macroglobulinemia
Condition: Waldenstrom Macroglobulinemia
Intervention: Drug: Revlimid
17 Recruiting The Comparison of RCD Versus BCD in Newly Diagnosed Waldenström Macroglobulinemia
Condition: Waldenström Macroglobulinemia
Interventions: Drug: Bortezomib;   Drug: Rituximab
18 Recruiting Fase II Study With BRB for Non-Hodgkin Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia's
Condition: Waldenstrom's Macroglobulinemia
Intervention: Drug: Bortezomib-Rituximab-Bendamustine
19 Active, not recruiting Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia
Condition: Waldenstrom's Macroglobulinemia
Interventions: Drug: Bortezomib;   Drug: Rituximab
20 Active, not recruiting Randomised Trial in Waldenstrom's Macroglobulinaemia
Condition: Waldenstrom's Macroglobulinaemia
Interventions: Drug: Bortezomib;   Drug: Cyclophosphamide;   Biological: Rituximab;   Drug: Fludarabine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.